Flinton Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$686K Buy
6,912
+336
+5% +$33.4K 0.02% 381
2019
Q2
$652K Buy
6,576
+64
+1% +$6.11K 0.02% 413
2019
Q1
$718K Buy
6,512
+1,584
+32% +$166K 0.02% 365
2018
Q4
$453K Buy
4,928
+704
+17% +$71.2K 0.02% 449
2018
Q3
$465K Buy
+4,224
New +$440K 0.01% 512

Other funds holding PRAH

Flinton Capital Management's PRAH Position: Q3 2019 in Review

Flinton Capital Management increased its PRA Health Sciences, Inc. (PRAH) stake by 5.1% in Q3 2019, buying an estimated $33.4K and bringing the position to 6,912 shares worth $686K. The position accounts for 0.02% of the portfolio, ranked #381.

Flinton Capital Management first reported a position in PRAH in Q3 2018 and has held it in 5 quarters since. The position peaked at $718K in Q1 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • Flinton Capital Management held 6,912 shares of PRA Health Sciences, Inc. worth $686K as of Q3 2019.
  • Flinton Capital Management bought 336 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $33.4K.
  • PRA Health Sciences, Inc. made up 0.02% of Flinton Capital Management's portfolio in Q3 2019, its #381 holding.
  • Flinton Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and has held it in 5 quarters since.
  • Flinton Capital Management's PRA Health Sciences, Inc. position peaked at $718K in Q1 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.